The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model.

Abstract:

:Current treatment strategies for chronic lymphocytic leukemia (CLL) involve a combination of conventional chemotherapeutics, monoclonal antibodies, and targeted signaling inhibitors. However, CLL remains largely incurable, with drug resistance and treatment relapse a common occurrence, leading to the search for novel treatments. Mechanistic target of rapamycin (mTOR)-specific inhibitors have been previously assessed but their efficacy is limited due to a positive feedback loop via mTOR complex 2 (mTORC2), resulting in activation of prosurvival signaling. In this study, we show that the dual phosphatidylinositol 3-kinase (PI3K)/mTOR inhibitor PF-04691502 does not induce an mTORC2 positive feedback loop similar to other PI3K inhibitors but does induce substantial antitumor effects. PF-04691502 significantly reduced survival coincident with the induction of Noxa and Puma, independently of immunoglobulin heavy chain variable region mutational status, CD38, and ZAP-70 expression. PF-04691502 inhibited both anti-immunoglobulin M-induced signaling and overcame stroma-induced survival signals and migratory stimuli from CXCL12. Equivalent in vitro activity was seen in the Eμ-TCL1 murine model of CLL. In vivo, PF-04691502 treatment of tumor-bearing animals resulted in a transient lymphocytosis, followed by a clear reduction in tumor in the blood, bone marrow, spleen, and lymph nodes. These data indicate that PF-04691502 or other dual PI3K/mTOR inhibitors in development may prove efficacious for the treatment of CLL, increasing our armamentarium to successfully manage this disease.

journal_name

Blood

journal_title

Blood

authors

Blunt MD,Carter MJ,Larrayoz M,Smith LD,Aguilar-Hernandez M,Cox KL,Tipton T,Reynolds M,Murphy S,Lemm E,Dias S,Duncombe A,Strefford JC,Johnson PW,Forconi F,Stevenson FK,Packham G,Cragg MS,Steele AJ

doi

10.1182/blood-2014-11-610329

subject

Has Abstract

pub_date

2015-06-25 00:00:00

pages

4032-41

issue

26

eissn

0006-4971

issn

1528-0020

pii

blood-2014-11-610329

journal_volume

125

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.

    abstract::BMS-354825 (dasatinib) and AMN107 (nilotinib) are potent alternate Abl inhibitors with activity against many imatinib mesylate-resistant BCR-ABL kinase domain (KD) mutants, except T315I. We used N-ethyl-N-nitrosourea (ENU)-exposed Ba/F3-p210(BCR-ABL) cells to compare incidence and types of KD mutants emerging in the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-004580

    authors: Bradeen HA,Eide CA,O'Hare T,Johnson KJ,Willis SG,Lee FY,Druker BJ,Deininger MW

    更新日期:2006-10-01 00:00:00

  • The human leukocyte integrin CD11a promoter directs expression in leukocytes of transgenic mice.

    abstract::The human CD11a molecule is expressed specifically on lymphocytes, monocyte/macrophages, and neutrophils, in which it mediates important adhesion-related functions. We used 1.7 kb of regulatory sequences upstream from the human CD11a gene transcription start site to drive expression of a modified human CD4 reporter ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ritchie KA,Aprikian A,Gollahon KA,Hickstein DD

    更新日期:1995-07-01 00:00:00

  • Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.

    abstract::Dense, dehydrated red blood cells (DRBCs) are a characteristic feature of sickle-cell disease (SCD). DRBCs play a role in the pathophysiology of SCD acute and chronic organ damage because of heightened tendency to undergo polymerization and sickling because of their higher hemoglobin S concentration. Relations between...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-424184

    authors: Bartolucci P,Brugnara C,Teixeira-Pinto A,Pissard S,Moradkhani K,Jouault H,Galacteros F

    更新日期:2012-10-11 00:00:00

  • von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.

    abstract::von Willebrand disease (VWD) is the most common autosomally inherited bleeding disorder. The disease represents a range of quantitative and qualitative pathologies of the adhesive glycoprotein von Willebrand factor (VWF). The pathogenic mechanisms responsible for the type 2 qualitative variants of VWF are now well cha...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-06-498303

    authors: Lillicrap D

    更新日期:2013-11-28 00:00:00

  • The munc13-4-rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane.

    abstract::Cytotoxic T lymphocytes (CTLs) kill target cells through the polarized release of lytic molecules from secretory lysosomes. Loss of munc13-4 function inhibits this process and causes familial hemophagocytic lymphohistiocytosis type 3 (FHL3). munc13-4 binds rab27a, but the necessity of the complex remains enigmatic, be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-339523

    authors: Elstak ED,Neeft M,Nehme NT,Voortman J,Cheung M,Goodarzifard M,Gerritsen HC,van Bergen En Henegouwen PM,Callebaut I,de Saint Basile G,van der Sluijs P

    更新日期:2011-08-11 00:00:00

  • FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation.

    abstract::Cytokine-induced expansion of hematopoietic stem and progenitor cells (HSPCs) is not fully understood. In the present study, we show that whereas steady-state hematopoiesis is normal in basic fibroblast growth factor (FGF-2)-knockout mice, parathyroid hormone stimulation and myeloablative treatments failed to induce n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-11-394692

    authors: Itkin T,Ludin A,Gradus B,Gur-Cohen S,Kalinkovich A,Schajnovitz A,Ovadya Y,Kollet O,Canaani J,Shezen E,Coffin DJ,Enikolopov GN,Berg T,Piacibello W,Hornstein E,Lapidot T

    更新日期:2012-08-30 00:00:00

  • Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis.

    abstract::Purified recombinant human heavy-chain (acidic) ferritin (rHF) was assessed in vivo in mice for effects on the proliferation (percentage of cells in S-phase) and absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in the femur and spleen and on the nuc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Williams DE,Geissler K,Hangoc G,Cooper S,Bicknell DC,Levi S,Arosio P

    更新日期:1989-01-01 00:00:00

  • Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.

    abstract::Human bone marrow (BM) cells contain low levels of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase, which may explain their susceptibility to nitrosourea-induced cytotoxicity and the development of secondary leukemia after nitrosourea treatment. Isolated CD34+ myeloid progenitors were also found to have l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gerson SL,Phillips W,Kastan M,Dumenco LL,Donovan C

    更新日期:1996-09-01 00:00:00

  • Transmaternal cell flow leads to antigen-experienced cord blood.

    abstract::Umbilical cord blood (UCB) is used for HSCT. It is known that UCB can comprise Ag-specific T cells. Here we question whether solely transmaternal cell flow may immunize UCB. Twenty-three female UCB samples were collected from healthy mothers and analyzed for minor histocompatibility Ag HY-specific responses. Forty-two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-410571

    authors: Dierselhuis MP,Blokland EC,Pool J,Schrama E,Scherjon SA,Goulmy E

    更新日期:2012-07-19 00:00:00

  • The reversible binding of vinblastine to platelets: implications for therapy.

    abstract::The ability of platelets to adsorb vinblastine has been used to treat patients with immune thrombocytopenia. It is hypothesized that the drug-platelet complex is coated with antibody, taken up by macrophages which are then destroyed by the drug. We gave 16 courses of vinblastine-platelets to six patients with immune t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelton JG,McDonald JW,Barr RM,Walker I,Nicholson W,Neame PB,Hamid C,Wong TY,Hirsh J

    更新日期:1981-03-01 00:00:00

  • BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair.

    abstract::Intracellular oxidative stress in cells transformed by the BCR-ABL oncogene is associated with increased DNA double-strand breaks. Imprecise repair of these breaks can result in the accumulation of mutations, leading to therapy-related drug resistance and disease progression. Using several BCR-ABL model systems, we fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-172148

    authors: Fernandes MS,Reddy MM,Gonneville JR,DeRoo SC,Podar K,Griffin JD,Weinstock DM,Sattler M

    更新日期:2009-08-27 00:00:00

  • Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

    abstract::Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is a complex oncogene, involving both fine protein dosage and cell-context dependency,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336842

    authors: Bonnet M,Loosveld M,Montpellier B,Navarro JM,Quilichini B,Picard C,Di Cristofaro J,Bagnis C,Fossat C,Hernandez L,Mamessier E,Roulland S,Morgado E,Formisano-Tréziny C,Dik WA,Langerak AW,Prebet T,Vey N,Michel G,Gabert

    更新日期:2011-06-16 00:00:00

  • Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.

    abstract::Administration of cyclosporine A (CsA) after autologous stem cell transplantation elicits an autoimmune syndrome with pathology similar to graft-versus-host disease (GVHD). This syndrome, termed autologous GVHD, is associated with the appearance of autoreactive T cells directed at major histocompatibility class (MHC) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.868

    authors: Miura Y,Thoburn CJ,Bright EC,Sommer M,Lefell S,Ueda M,Nakao S,Hess AD

    更新日期:2001-08-01 00:00:00

  • Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.

    abstract::Both total metabolic tumor volume (TMTV), computed on baseline positron emission tomography (PET), and end of induction (EOI) PET are imaging biomarkers showing promise for early risk stratification in patients with high-tumor-burden follicular lymphoma. A model was built incorporating these 2 factors in 159 patients ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2017-11-816298

    authors: Cottereau AS,Versari A,Luminari S,Dupuis J,Chartier L,Casasnovas RO,Berriolo-Riedinger A,Menga M,Haioun C,Tilly H,Tarantino V,Federico M,Salles G,Trotman J,Meignan M

    更新日期:2018-05-31 00:00:00

  • Erythropoiesis-stimulating factor production by rabbit kidney cultures from "programmed" rabbits.

    abstract::Rabbit kidney tissue either from normal rabbits or from rabbits "programmed" by phlebotomy or varying periods of hypoxia was cultured and shown to release into the culture medium an erythropoietically active substance. The cultures established from rabbits programmed by 6-12 hr of hypoxia yielded the highest levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ogle JW,Lange RD,Dunn CD

    更新日期:1978-07-01 00:00:00

  • Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector.

    abstract::Gene therapy for hemophilia A requires efficient delivery of the factor VIII gene and sustained protein expression at circulating levels of at least 1% to 2% of normal. Adeno-associated viral type 2 (AAV2) vectors have a number of advantages over other viral vectors, including an excellent safety profile and persisten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0292

    authors: Scallan CD,Lillicrap D,Jiang H,Qian X,Patarroyo-White SL,Parker AE,Liu T,Vargas J,Nagy D,Powell SK,Wright JF,Turner PV,Tinlin SJ,Webster SE,McClelland A,Couto LB

    更新日期:2003-09-15 00:00:00

  • Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.

    abstract::Tissue-type plasminogen activator (t-PA) is less active in vivo and in vitro against clots that are enriched in platelets, even at therapeutic concentrations. The release of radioactivity from 125I-fibrin-labeled clots was decreased by 47% 6 hours after the addition of t-PA 400 U/mL when formed in platelet-rich versus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kunitada S,FitzGerald GA,Fitzgerald DJ

    更新日期:1992-03-15 00:00:00

  • A special report: bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee.

    abstract::A primary function of the World Marrow Donor Association is to establish general guidelines covering collaboration between international donor registries and practice in regard to bone marrow transplants (BMTs) in which the donor and recipient reside in different countries. To this end, a special report proposing spec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goldman JM

    更新日期:1994-11-01 00:00:00

  • Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival.

    abstract::Human neutrophils possess a very short half-life because they constitutively undergo apoptosis. Cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), and other agents can rescue neutrophils from apoptosis but the molecular mechanisms involved in this rescue are undefined. Here, we show by Weste...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moulding DA,Quayle JA,Hart CA,Edwards SW

    更新日期:1998-10-01 00:00:00

  • Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.

    abstract::The differentiation of human peripheral blood monocytes into resident macrophages is driven by colony-stimulating factor-1 (CSF-1), which upon interaction with CSF-1 receptor (CSF-1R) induces within minutes the phosphorylation of its cytoplasmic tyrosine residues and the activation of multiple signaling complexes. Cas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208843

    authors: Jacquel A,Benikhlef N,Paggetti J,Lalaoui N,Guery L,Dufour EK,Ciudad M,Racoeur C,Micheau O,Delva L,Droin N,Solary E

    更新日期:2009-10-22 00:00:00

  • The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

    abstract::NOTCH1 and SF3B1 mutations have been previously reported to have prognostic significance in chronic lymphocytic leukemia but to date they have not been validated in a prospective, controlled clinical trial. We have assessed the impact of these mutations in a cohort of 494 patients treated within the randomized phase 3...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2012-05-429282

    authors: Oscier DG,Rose-Zerilli MJ,Winkelmann N,Gonzalez de Castro D,Gomez B,Forster J,Parker H,Parker A,Gardiner A,Collins A,Else M,Cross NC,Catovsky D,Strefford JC

    更新日期:2013-01-17 00:00:00

  • Epithelial cytoprotection sustains ectopic expression of tissue-restricted antigens in the thymus during murine acute GVHD.

    abstract::Development of acute graft-versus-host disease (aGVHD) predisposes to chronic GVHD with autoimmune manifestations. A characteristic of experimental aGVHD is the de novo generation of autoreactive T cells. Central tolerance is dependent on the intrathymic expression of tissue-restricted peripheral self-antigens (TRA), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-474759

    authors: Dertschnig S,Nusspaumer G,Ivanek R,Hauri-Hohl MM,Holländer GA,Krenger W

    更新日期:2013-08-01 00:00:00

  • Plasmablasts derive from CD23-negative activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction.

    abstract::The terminal differentiation of B cells into antibody-secreting cells (ASCs) is a critical component of adaptive immune responses. However, it is a very sensitive process, which dysfunctions lead to a great variety of lymphoproliferative neoplasia including germinal center-derived lymphomas. To better characterize the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005083

    authors: Pignarre A,Chatonnet F,Caron G,Haas M,Desmots-Loyer F,Fest T

    更新日期:2020-11-04 00:00:00

  • Hematopoietic stem cell transplantation for infantile osteopetrosis.

    abstract::We report the international experience in outcomes after related and unrelated hematopoietic transplantation for infantile osteopetrosis in 193 patients. Thirty-four percent of transplants used grafts from HLA-matched siblings, 13% from HLA-mismatched relatives, 12% from HLA-matched, and 41% from HLA-mismatched unrela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-625541

    authors: Orchard PJ,Fasth AL,Le Rademacher J,He W,Boelens JJ,Horwitz EM,Al-Seraihy A,Ayas M,Bonfim CM,Boulad F,Lund T,Buchbinder DK,Kapoor N,O'Brien TA,Perez MA,Veys PA,Eapen M

    更新日期:2015-07-09 00:00:00

  • Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

    abstract::In the present study, we investigated disease characteristics and clinical outcome in young patients (< 40 years) with World Health Organization (WHO)-defined essential thrombocythemia (ET) compared with early/prefibrotic primary myelofibrosis (PMF) with presenting thrombocythemia. We recruited 213 young patients (med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-407981

    authors: Barbui T,Thiele J,Carobbio A,Passamonti F,Rumi E,Randi ML,Bertozzi I,Vannucchi AM,Gisslinger H,Gisslinger B,Finazzi G,Ruggeri M,Rodeghiero F,Rambaldi A,Gangat N,Tefferi A

    更新日期:2012-07-19 00:00:00

  • Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.

    abstract::Most bone marrow (BM) malignancies develop in association with an angiogenic phenotype and increased numbers of endothelial cells. The molecular mechanisms involved in the modulation and recruitment of BM endothelium are largely unknown and may provide novel therapeutic targets for neoplastic diseases. We observed tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2208

    authors: Costa LF,Balcells M,Edelman ER,Nadler LM,Cardoso AA

    更新日期:2006-01-01 00:00:00

  • Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.

    abstract::Conventional assays evaluating antitumor activity of immune effector cells have limitations that preclude their high-throughput application. We adapted the recently developed Compartment-Specific Bioluminescence Imaging (CS-BLI) technique to perform high-throughput quantification of innate antitumor activity and to sh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-348490

    authors: McMillin DW,Delmore J,Negri JM,Vanneman M,Koyama S,Schlossman RL,Munshi NC,Laubach J,Richardson PG,Dranoff G,Anderson KC,Mitsiades CS

    更新日期:2012-04-12 00:00:00

  • CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

    abstract::CD4(+), CD56(+) DC2 malignancies constitute a novel disease entity, which has recently been shown to arise from a transformed lymphoid-related plasmacytoid dendritic cell (DC2). Diagnosis is primarily based on a particular immunophenotype with tumor cells expressing CD4 and CD56 antigens in the absence of common lymph...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.v99.11.4154

    authors: Leroux D,Mugneret F,Callanan M,Radford-Weiss I,Dastugue N,Feuillard J,Le Mée F,Plessis G,Talmant P,Gachard N,Uettwiller F,Pages MP,Mozziconacci MJ,Eclache V,Sibille C,Avet-Loiseau H,Lafage-Pochitaloff M

    更新日期:2002-06-01 00:00:00

  • Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected.

    abstract::Human herpesvirus 8 (HHV-8) genomic sequences were recently detected by polymerase chain reaction (PCR) and in situ hybridization in bone marrow stromal cells grown from multiple myeloma (MM) patients, but not in cells from control subjects (Rettig et al, Science 276:1851, 1997). We sought to confirm these observation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tisdale JF,Stewart AK,Dickstein B,Little RF,Dubé I,Cappe D,Dunbar CE,Brown KE

    更新日期:1998-10-15 00:00:00

  • Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

    abstract::Diffuse large B-cell lymphoma (DLBCL) consists of at least 2 phenotypic subtypes; that is, the germinal center B-cell-like (GCB-DLBCL) and the activated B-cell-like (ABC-DLBCL) groups. It has been shown that GCB-DLBCL responds favorably to chemotherapy and expresses high levels of BCL6, a transcription repressor known...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-087734

    authors: Ding BB,Yu JJ,Yu RY,Mendez LM,Shaknovich R,Zhang Y,Cattoretti G,Ye BH

    更新日期:2008-02-01 00:00:00